Basler AG header image

Basler AG

BSL

Equity

ISIN DE0005102008 / Valor 207929

Xetra (2026-01-20)
EUR 16.50+0.98%

Basler AG
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Basler AG is a company that specializes in the development and production of high-quality industrial cameras for various applications. As a leading manufacturer in the industry, Basler AG provides innovative solutions for businesses looking to enhance their imaging systems. With a focus on quality and reliability, the company's industrial cameras are designed to meet the demands of a wide range of industries, including manufacturing, medical imaging, and traffic monitoring. Through its cutting-edge technology and commitment to excellence, Basler AG continues to be a trusted partner for businesses seeking top-of-the-line imaging solutions.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (24.12.2025):

Basler AG — Q1 2025 summary: Basler started 2025 with a strong operational recovery. Sales rose to €59.5m in Q1 2025 (up 37% year‑on‑year) and incoming orders were €52.1m (+18% y/y). Profitability moved back into positive territory with EBITDA of €10.1m and EBT of €6.0m (EBT margin 10.0%), producing a net profit of €4.8m and earnings per share of €0.16. Management confirms its 2025 guidance (sales €186–198m; pre‑tax margin 0–5%) while flagging limited visibility, US tariffs and currency risks.

Sales & orders

Q1 2025 sales: €59.5m (+37% vs Q1 2024). Incoming orders: €52.1m (+18% vs prior year). Business strength was driven by major projects in China and the USA.

Profitability

Gross profit €28.6m and gross margin 48.1% (up 3.5 percentage points y/y). EBITDA €10.1m (previously €1.0m) and EBT €6.0m (vs -€3.6m), yielding net income €4.8m (vs -€3.9m) and EPS €0.16 (vs -€0.13).

Cash flow & liquidity

Operating cash flow turned positive at €0.4m (vs -€1.1m). Free cash flow improved to -€2.2m (from -€3.4m). Cash and cash equivalents at 31 Mar 2025 were €16.1m (down from €21.3m at year‑end).

Balance sheet & capital structure

Equity rose to €128.8m, equity ratio improved to 55.3% (from 53.3%). Inventories were reduced (to €35.3m) while trade receivables increased (to €38.7m) due to higher sales. Number of employees: 849 FTEs.

Guidance, risks and management actions

Management reconfirms FY2025 guidance (sales €186–198m; pre‑tax margin 0–5%). Key risks: newly introduced US tariffs, currency fluctuations and limited customer order visibility. Measures to limit tariff impact and strict cost discipline are in place.

Regional mix & market notes

Regional sales split Q1 2025: Asia 47%, EMEA 30%, Americas 23%. Above‑average growth in China and the USA; Europe grew more slowly. Management notes ongoing price pressure, especially in China.

Costs, R&D and strategic progress

Cost‑cutting program largely completed; break‑even lowered to ~€180m. Full costs for R&D in Q1 €7.5m (R&D ratio ~12.6% in context). No major new product launches in Q1, but continuing product enhancements and trade‑show presence (LogiMAT).

Market reaction & capital market

Basler AG share closed at €8.70 on 31 Mar 2025 (vs €6.12 at 31 Dec 2024, +42%). Management has stepped up investor outreach and will continue transparent reporting through the year.

Summarized from source with an LLMView Source

Key figures

146%1Y
-55.6%3Y
-42.4%5Y

Performance

59.2%1Y
52.4%3Y
51.4%5Y

Volatility

Market cap

594 M

Market cap (USD)

Daily traded volume (Shares)

34,964

Daily traded volume (Shares)

1 day high/low

6.04 / 5.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Leonie Baumeler
Switzerland, 30 Mar 2025
star star star star star

EQUITIES OF THE SAME SECTOR

Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Valor: 965755
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%USD 733.78
INTERSHOP Communications AG
INTERSHOP Communications AG INTERSHOP Communications AG Valor: 52515678
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.30%EUR 1.35
artnet AG
artnet AG artnet AG Valor: 13664519
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 11.30
SEVEN PRINCIPLES AG
SEVEN PRINCIPLES AG SEVEN PRINCIPLES AG Valor: 30741641
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.64%EUR 4.80
NanoRepro AG
NanoRepro AG NanoRepro AG Valor: 4691951
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.19%EUR 1.56
beaconsmind Ltd
beaconsmind Ltd beaconsmind Ltd Valor: 45112358
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%EUR 5.60
Schweizer Electronic AG
Schweizer Electronic AG Schweizer Electronic AG Valor: 1218002
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.83%EUR 6.05
Bio-Gate AG
Bio-Gate AG Bio-Gate AG Valor: 20104373
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.50%EUR 0.78
Exelixis Inc
Exelixis Inc Exelixis Inc Valor: 1069927
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 43.78
Mynaric AG
Mynaric AG Mynaric AG Valor: 121337525
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 0.17